Home › Cancro al seno triplo negativo › Indiana › Indianapolis
Studi clinici su Cancro al seno triplo negativo a Indianapolis, IN
9 studi su Cancro al seno triplo negativo cercano partecipanti presso sedi a Indianapolis e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
In reclutamentoFase 1
- IU Simon Cancer Center, Indianapolis
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
In reclutamentoFase 3
- Franciscan Health ( Site 0077), Indianapolis
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
In reclutamentoFase 3
- Franciscan Health Indianapolis, Indianapolis
Toci +/- SOC Chemo for Metastatic Triple Negative and ER-positive, HER2-negative Breast Cancers
In reclutamentoFase 2
- Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
- Sidney and Lois Eskenazi Hospital, Indianapolis
A Study of LY4175408 in Participants With Advanced Cancer
In reclutamentoFase 1
- Community Health Network, Indianapolis
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
In reclutamentoFase 1
- Community Health Network, Inc. /ID# 243011, Indianapolis
A Study of Tetrathiomolybdate (TM) Plus Capecitabine
In reclutamentoFase 1/2
- Indiana University Simon Cancer Center, Indianapolis
NearWave Optical Molecular Monitoring
In reclutamento
- Indiana University Simon Comprehensive Cancer Center, Indianapolis
A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
In reclutamentoFase 1/2
- Community Health Network, Indianapolis
Studi su Cancro al seno triplo negativo in altre città
- Houston, TX42 studi
- New York City, NY31 studi
- Nashville, TN28 studi
- Los Angeles, CA27 studi
- Boston, MA26 studi
- San Antonio, TX23 studi
- St. Louis, MO21 studi
- Arlington, VA20 studi
- Atlanta, GA20 studi
- Dallas, TX18 studi
- Chicago, IL16 studi
- Columbus, OH16 studi
Altri studi a Indianapolis
- Cancro del polmone non a piccole cellule32 studi
- Cancro (tutti i tipi)24 studi
- Insufficienza cardiaca23 studi
- Obesità20 studi
- Cancro al seno20 studi
- Cancro metastatico19 studi
- Cancro colorettale18 studi
- Cancro ovarico17 studi
- Malattie cardiovascolari17 studi
- Cancro ai polmoni16 studi
- Diabete di tipo 114 studi
- Cancro dell'endometrio14 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.